PRUITT MICHAEL D (CEO, Chairman) purchased 25.5% of their position (7.21K shares) of SONNET BIOTHERAPEUTICS HOLDINGS, INC. on the open market
Open‑market purchase worth $4.1K — a significant purchase. The strongest form of insider conviction signal.
P · 3 purchases
Filed: 3/24/2020ACC: 0001493152-20-004588
DirectorOfficer· CEO, Chairman
Since Aug 2018
+7.21K
Net shares
Net buyer
$4.1K
Total acquired
3
Open market trades
3B · 0S
3
Total transactions
7.21K acquired
Non-Derivative Transactions3
Common Stock
Indirect
Shares
+206.00
Price / share
—
Trade value
—
% of position
2.1%
1/31/2020
10.02K→10.22K
Common Stock
Indirect
Shares
+5K
Price / share
$0.60
Trade value
$3K
% of position
92.1%
3/23/2020
5.43K→10.43K
Common Stock
Indirect
Shares
+2K
Price / share
$0.54
Trade value
$1.08K
% of position
6.0%
3/23/2020
33.46K→35.46K
Total
Net shares
+7.21K
Net value
$4.08K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 1/31/2020 | P · Purchase | +206.00 | — | — | 2.1% | 10.02K | 10.22K |
| Common Stock Indirect | 3/23/2020 | P · Purchase | +5K | $0.60 | $3K | 92.1% | 5.43K | 10.43K |
| Common Stock Indirect | 3/23/2020 | P · Purchase | +2K | $0.54 | $1.08K | 6.0% | 33.46K | 35.46K |
| Total | +7.21K | $4.08K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)2
Series 1 Preferred Stock
IndirectShares owned340.00
Common Stock
DirectShares owned17.26K
Total
17.26K direct·340.00 indirect17.60K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Series 1 Preferred Stock | 340.00 | Indirect |
| Common Stock | 17.26K | Direct |
| Total | 17.60K | 17.26K direct·340.00 indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported